Takako Araki, MD

Assistant Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism

Takako Araki

Contact Info

Mailing Address:
420 Delaware Street SE
MMC 101
Minneapolis, MN 55455

Administrative Assistant Name
Pam Wenner

Administrative Email

Assistant Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism

Medical School, Nagasaki University School of Medicine, Nagasaki, Japan

Residency, Mount Sinai Beth Israel Medical Center, New York, NY

Fellowship, Cedars-Sinai Medical Center, Los Angeles, CA

Bachelors, Kyushu University, Fukuoka-ken, Japan


Dr. Takako Araki graduated from Nagasaki University School of Medicine in Nagasaki, Japan. She completed her Internal Medicine residency training and Endocrinology fellowship from Mount Sinai Beth Israel, NY. She also completed her postdoctoral and clinical fellow ship from Cedars-Sinai Medical Center, Los Angeles, CA in 2015. Dr. Araki is currently an Assistant Professor in Division of Endocrinology, Diabetes and Metabolism at University of Minnesota. Her research is focused on quality improvement of pituitary perioperative patient care and pituitary/neuroendocrine hormone regulations.


  • Acromegaly
  • Cushing's syndrome
  • Hypopituitarism
  • Diabetes 
  • Endocrinology
  • Pituitary Disease

Awards & Recognition

  • NIH T32 Training Grant (Melmed PI) (2013)
  • Friedman Research Fellowship, Friedman Foundation, NY, USA (2008)
  • Mitsui Awards for Young Japanese Physicians in the USA, Japanese Medical Society of America, NY, USA (2008)
  • N Program Scholar Award, Tokio Marine Foundation, Tokyo, Japan (2008)

Professional Associations

  • North American Skull Base Society
  • Member, Pituitary Society
  • Member, Endocrine Society


Research Summary/Interests

  • Gene regulations of pituitary/neuroendocrine tumors
  • Quality Improvement of Pituitary Preoperative Patient Care


  • Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A, Yamada S, Takeshita A, Yamamoto M, Kawakami Y, Tone M, Melmed S. Two Distinctive POMC Promoters Modify Gene Expression in Cushing's Disease. J Clin Endocrinol Metab. 2021 Jun 1, PubMed PMID: 34061962.
  • Araki T, Sangtian J, Ruanpeng D, Tummala R, Clark B, Burmeister L, Peterson D, Venteicher AS, Kawakami Y. Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease. Pituitary. 2021 May 26, PubMed PMID: 34041660
  • Araki T, Liu X, Kameda H, Tone Y, Fukuoka H, Tone M, Melmed S. EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis.J. Endocr. Soc. (2017) 1(2): 127-143.
  • Araki T, Liu NA, Tone Y, Cuevas-Ramos D, Heltsley R, Tone M, Melmed S. E2F1-mediated human POMC expression in ectopic Cushing’s syndrome.Endocr Relat Cancer.(2016) 23(11):857-87
  • Liu NA*Araki T* (co-first), Cuevas-Ramos D, Hong J, Ben-Shlomo A, Tone Y, Tone M, Melmed S. Cyclin E-mediated human proopiomelanocortin regulation as a therapeutic target for Cushing disease.J Clin Endocrinol Metab.(2015) 100(7):2557-64.



Clinics and Surgery Center

Board Certifications

  • Internal Medicine
  • Endocrinology and Metabolism

Clinical Interests

Pituitary Disorders; Diabetes; Adrenal; Bone; Thyroid; Osteoporosis

Hospital Privileges

University of Minnesota Medical Center, Fairview